Abstract Objectives Systemic sclerosis (SSc) is an autoimmune disease characterized by peripheral vasculopathy and skin and internal organ fibrosis. Accumulating evidence underlines a close association between a metabolic reprogramming of activated fibroblasts and fibrosis. This prompted us to determine the metabolism of SSc dermal fibroblasts and the effect on the vasculopathy characterizing the disease. Methods Seahorse XF96 Extracellular Flux Analyzer was exploited to evaluate SSc fibroblast metabolism. In vitro invasion and capillary morphogenesis assays were used to determine the angiogenic ability of endothelial cells (EC). Immunofluorescence, flow cytometer and real time PCR techniques provided evidence of the molecular mechanism behind the impaired vascularization that characterizes SSc patients. Results SSc fibroblasts, compared with control, showed a boosted glycolytic metabolism with increased lactic acid release and subsequent extracellular acidification, that in turn was found to impair EC invasion and organization in capillary-like networks without altering cell viability. A molecular link between extracellular acidosis and endothelial dysfunction was identified as acidic EC up-regulated MMP-12 which cleaves and inactivates uPAR, impairing angiogenesis in SSc. Moreover, the acidic environment was found to induce the loss of endothelial markers and the acquisition of mesenchymal-like features in EC, thus promoting the endothelial-to-mesenchymal transition (EndoMT) process that contributes to both capillary rarefaction and tissue fibrosis in SSc. Conclusion This study disclosed a liaison among the metabolic reprogramming of SSc dermal fibroblasts, extracellular acidosis and endothelial dysfunction that may contribute to the impairment and loss of peripheral capillary networks in SSc disease.

Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis / Andreucci, Elena; Margheri, Francesca; Peppicelli, Silvia; Bianchini, Francesca; Ruzzolini, Jessica; Laurenzana, Anna; Fibbi, Gabriella; Bruni, Cosimo; Bellando-Randone, Silvia; Guiducci, Serena; Romano, Eloisa; Manetti, Mirko; Matucci-Cerinic, Marco; Calorini, Lido. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 60:(2021), pp. 4508-4519. [10.1093/rheumatology/keab022]

Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis

Andreucci, Elena;Margheri, Francesca;Peppicelli, Silvia;Bianchini, Francesca;Ruzzolini, Jessica;Laurenzana, Anna;Fibbi, Gabriella;Bruni, Cosimo;Bellando-Randone, Silvia;Guiducci, Serena;Romano, Eloisa;Manetti, Mirko;Matucci-Cerinic, Marco;Calorini, Lido
2021

Abstract

Abstract Objectives Systemic sclerosis (SSc) is an autoimmune disease characterized by peripheral vasculopathy and skin and internal organ fibrosis. Accumulating evidence underlines a close association between a metabolic reprogramming of activated fibroblasts and fibrosis. This prompted us to determine the metabolism of SSc dermal fibroblasts and the effect on the vasculopathy characterizing the disease. Methods Seahorse XF96 Extracellular Flux Analyzer was exploited to evaluate SSc fibroblast metabolism. In vitro invasion and capillary morphogenesis assays were used to determine the angiogenic ability of endothelial cells (EC). Immunofluorescence, flow cytometer and real time PCR techniques provided evidence of the molecular mechanism behind the impaired vascularization that characterizes SSc patients. Results SSc fibroblasts, compared with control, showed a boosted glycolytic metabolism with increased lactic acid release and subsequent extracellular acidification, that in turn was found to impair EC invasion and organization in capillary-like networks without altering cell viability. A molecular link between extracellular acidosis and endothelial dysfunction was identified as acidic EC up-regulated MMP-12 which cleaves and inactivates uPAR, impairing angiogenesis in SSc. Moreover, the acidic environment was found to induce the loss of endothelial markers and the acquisition of mesenchymal-like features in EC, thus promoting the endothelial-to-mesenchymal transition (EndoMT) process that contributes to both capillary rarefaction and tissue fibrosis in SSc. Conclusion This study disclosed a liaison among the metabolic reprogramming of SSc dermal fibroblasts, extracellular acidosis and endothelial dysfunction that may contribute to the impairment and loss of peripheral capillary networks in SSc disease.
2021
60
4508
4519
Goal 3: Good health and well-being for people
Andreucci, Elena; Margheri, Francesca; Peppicelli, Silvia; Bianchini, Francesca; Ruzzolini, Jessica; Laurenzana, Anna; Fibbi, Gabriella; Bruni, Cosimo...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1222615
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 17
social impact